IL164523A0 - Cytokine receptor - Google Patents

Cytokine receptor

Info

Publication number
IL164523A0
IL164523A0 IL16452304A IL16452304A IL164523A0 IL 164523 A0 IL164523 A0 IL 164523A0 IL 16452304 A IL16452304 A IL 16452304A IL 16452304 A IL16452304 A IL 16452304A IL 164523 A0 IL164523 A0 IL 164523A0
Authority
IL
Israel
Prior art keywords
polypeptide
seq
amino acids
level
sample
Prior art date
Application number
IL16452304A
Other languages
English (en)
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of IL164523A0 publication Critical patent/IL164523A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16452304A 2002-04-19 2004-10-12 Cytokine receptor IL164523A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37381302P 2002-04-19 2002-04-19
PCT/US2003/012030 WO2003089603A2 (en) 2002-04-19 2003-04-18 Cytokine receptor

Publications (1)

Publication Number Publication Date
IL164523A0 true IL164523A0 (en) 2005-12-18

Family

ID=29251089

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16452304A IL164523A0 (en) 2002-04-19 2004-10-12 Cytokine receptor

Country Status (13)

Country Link
US (7) US20040029228A1 (de)
EP (2) EP2295455A1 (de)
JP (2) JP4409962B2 (de)
CN (2) CN1659274A (de)
AT (1) ATE493438T1 (de)
AU (2) AU2003225055B2 (de)
BR (1) BR0309401A (de)
CA (1) CA2482368A1 (de)
DE (1) DE60335536D1 (de)
ES (1) ES2356307T3 (de)
IL (1) IL164523A0 (de)
RU (1) RU2004133765A (de)
WO (1) WO2003089603A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004532611A (ja) * 2000-11-28 2004-10-28 ザイモジェネティクス,インコーポレイティド サイトカイン受容体zcytor19
TW200300170A (en) * 2001-11-09 2003-05-16 Wyeth Corp Type 2 cytokine receptor and nucleic acids encoding same
AU2003215136A1 (en) * 2002-02-08 2003-09-02 University Of Medicine And Dentistry Of New Jersey Ifn-a/b-independent mechanism of antiviral protection
JP4409962B2 (ja) * 2002-04-19 2010-02-03 ザイモジェネティクス,インコーポレイティド サイトカイン受容体
JP2006509041A (ja) 2002-10-23 2006-03-16 ザイモジェネティクス,インコーポレイティド Il−28およびil−29を用いるウイルス感染を治療するための方法
DK1668031T3 (da) 2003-08-07 2008-06-30 Zymogenetics Inc Homogene præparater af IL-29
US20050244423A1 (en) * 2004-04-02 2005-11-03 Klucher Kevin M Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
US7351689B2 (en) * 2004-07-29 2008-04-01 Zymogenetics, Inc. Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
JP4987001B2 (ja) * 2005-07-20 2012-07-25 ザイモジェネティクス リミテッド ライアビリティ カンパニー 癌および自己免疫障害を処置するためのil28およびil29の短縮型システイン変異体の使用法
JP2009502803A (ja) * 2005-07-20 2009-01-29 ザイモジェネティクス, インコーポレイテッド Il−28およびil−29のシステイン欠失変異体、ならびにそれを用いる抗ウイルス法
WO2013103981A1 (en) * 2012-01-06 2013-07-11 Ember Therapeutics, Inc. Compositions and methods of use of fndc5 polypeptides
EP2617732A1 (de) * 2012-01-19 2013-07-24 Vib Vzw Werkzeuge und Verfahren zur Expression von Membranproteinen
GB201514875D0 (en) * 2015-08-20 2015-10-07 Autolus Ltd Receptor
AU2016369490C1 (en) 2015-12-18 2021-12-23 Sangamo Therapeutics, Inc. Targeted disruption of the T cell receptor

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US846A (en) 1838-07-17 Improvement in revolving fire-arms
US5738A (en) 1848-08-29 Francis kelsey
DK368882A (da) 1981-08-25 1983-02-26 Alan John Kingsman Expessions vektorer
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4624846A (en) 1983-07-29 1986-11-25 Immunomedics, Inc. Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
DE3578435D1 (de) 1984-12-06 1990-08-02 Labofina Sa Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden.
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
US5057313A (en) 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5055291A (en) 1986-11-04 1991-10-08 Baylor College Of Medicine Compositions for preventing secondary cataracts
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
ES2092468T3 (es) 1988-01-22 1996-12-01 Zymogenetics Inc Metodos para producir analogos de receptores secretados.
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US5529932A (en) 1988-01-28 1996-06-25 Pharmacia, S.P.A. Isolated DNA encoding a plant ribosome inactivating protein from the leaves of saponaria officinalis
US5120525A (en) 1988-03-29 1992-06-09 Immunomedics, Inc. Radiolabeled antibody cytotoxic therapy of cancer
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5576288A (en) 1989-04-27 1996-11-19 The Salk Institute For Biological Studies Fibroblast growth factor conjugates
US5191067A (en) 1989-04-27 1993-03-02 The Salk Institute For Biological Studies Fibroblast growth factor conjugates
US5162222A (en) 1989-07-07 1992-11-10 Guarino Linda A Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
US5635384A (en) 1990-06-11 1997-06-03 Dowelanco Ribosome-inactivating proteins, inactive precursor forms thereof, a process for making and a method of using
US5478804A (en) 1990-09-19 1995-12-26 The Salk Institute For Biological Studies Treatment of tumorigenic pathophysiological conditions with FGF-cytoxic conjugates
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
JPH06504438A (ja) 1990-12-13 1994-05-26 イミュネックス・コーポレーション 白血病抑制因子受容体
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
WO1994006463A1 (en) 1992-09-14 1994-03-31 Pfizer Inc Immortalized cells and uses therefor
WO1994020540A1 (es) 1993-03-02 1994-09-15 Universidad De Valladolid PROTEINAS INACTIVADORAS DE RIBOSOMAS (RIPs) DE DOS CADENAS NO TOXICAS, PROCEDIMIENTO PARA SU PREPARACION Y APLICACIONES
CA2171192A1 (en) 1993-09-06 1995-03-16 Fiorenzo Stirpe Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them
US5443953A (en) 1993-12-08 1995-08-22 Immunomedics, Inc. Preparation and use of immunoconjugates
WO1995021930A2 (en) 1994-02-14 1995-08-17 Zymogenetics, Inc. Method for preparing orphan receptor ligands
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5911995A (en) 1994-08-19 1999-06-15 Regents Of The University Of Minnesota EGF-genistein conjugates for the treatment of cancer
US5738846A (en) 1994-11-10 1998-04-14 Enzon, Inc. Interferon polymer conjugates and process for preparing the same
WO1997017450A2 (en) 1995-11-09 1997-05-15 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in pichia methanolica
IT1286663B1 (it) 1996-06-27 1998-07-15 Ministero Uni Ricerca Scient E Proteina capace di inibire l'attivita' ribosomiale,sua preparazione ed uso come immunoconiugato chimico o ricombinante e sequenza di cdna
IL128073A0 (en) 1996-07-17 1999-11-30 Zymogenetics Inc Transformation of pichia methanolica
JP2002514049A (ja) 1996-07-17 2002-05-14 ザイモジェネティクス,インコーポレイティド ピヒア・メタノリカの栄養要求性突然変異体の製造
CA2273194C (en) 1996-12-03 2011-02-01 Abgenix, Inc. Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
US5945511A (en) 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
AU8040898A (en) 1997-06-06 1998-12-21 Tanox Pharma B.V. Type-1 ribosome-inactivating protein
US5965704A (en) 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
EP1131333B1 (de) 1998-10-26 2010-06-02 Wyeth a Corporation of the State of Delaware Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
AU6069300A (en) 1999-07-02 2001-01-22 Chiron Corporation Novel human genes and gene expression products
CN100448993C (zh) 2000-06-30 2009-01-07 津莫吉尼蒂克斯公司 干扰素样蛋白质Zcyto21
DE10031389A1 (de) * 2000-07-03 2002-01-17 Knoll Ag Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
JP2004509617A (ja) * 2000-09-08 2004-04-02 シェーリング コーポレイション 哺乳動物遺伝子;関連試薬および方法
JP2004532611A (ja) * 2000-11-28 2004-10-28 ザイモジェネティクス,インコーポレイティド サイトカイン受容体zcytor19
CN100482684C (zh) * 2001-04-20 2009-04-29 津莫吉尼蒂克斯公司 细胞因子蛋白质家族
EP1439223A1 (de) 2001-10-02 2004-07-21 Mochida Pharmaceutical Co., Ltd. Neuer klasse-ii-cytokinrezeptor
TW200300170A (en) 2001-11-09 2003-05-16 Wyeth Corp Type 2 cytokine receptor and nucleic acids encoding same
US7033787B2 (en) * 2001-12-21 2006-04-25 Ludwig Institute For Cancer Research Isolated cytokine receptor LICR-2
AU2003215136A1 (en) 2002-02-08 2003-09-02 University Of Medicine And Dentistry Of New Jersey Ifn-a/b-independent mechanism of antiviral protection
JP4409962B2 (ja) * 2002-04-19 2010-02-03 ザイモジェネティクス,インコーポレイティド サイトカイン受容体
JP2006509041A (ja) * 2002-10-23 2006-03-16 ザイモジェネティクス,インコーポレイティド Il−28およびil−29を用いるウイルス感染を治療するための方法
JP2009520459A (ja) * 2003-02-14 2009-05-28 サイグレス ディスカバリー, インコーポレイテッド 癌における治療標的

Also Published As

Publication number Publication date
EP1497415A2 (de) 2005-01-19
CA2482368A1 (en) 2003-10-30
US20120053321A1 (en) 2012-03-01
JP2006504401A (ja) 2006-02-09
ATE493438T1 (de) 2011-01-15
US20040029228A1 (en) 2004-02-12
EP2295455A1 (de) 2011-03-16
CN101676728A (zh) 2010-03-24
ES2356307T3 (es) 2011-04-06
AU2003225055B2 (en) 2009-04-23
WO2003089603A3 (en) 2004-09-16
US7723298B2 (en) 2010-05-25
CN1659274A (zh) 2005-08-24
US20070048847A1 (en) 2007-03-01
US20110171627A1 (en) 2011-07-14
US20070264685A1 (en) 2007-11-15
BR0309401A (pt) 2007-02-21
WO2003089603A2 (en) 2003-10-30
AU2009203007A1 (en) 2009-08-13
EP1497415B1 (de) 2010-12-29
RU2004133765A (ru) 2005-06-27
AU2003225055A1 (en) 2003-11-03
US20070134727A1 (en) 2007-06-14
EP1497415A4 (de) 2006-03-22
JP4409962B2 (ja) 2010-02-03
DE60335536D1 (de) 2011-02-10
US20070122879A1 (en) 2007-05-31
JP2009268469A (ja) 2009-11-19

Similar Documents

Publication Publication Date Title
IL164523A0 (en) Cytokine receptor
DE69331550D1 (de) Klonierung und expression von biologisch aktiver alpha-galaktosidase a
FI107610B (fi) HCV-fuusioproteiini
IL210455A (en) A polypeptide for reducing mammalian signaling 13il, and using a polypeptide to produce a drug for up-regulating gene expression 2ra13-il in mammals
SI0935660T1 (sl) Infekcijski kloni RNA virusov ter cepiva in diagnostični testi, izvedeni iz le-teh
IL145288A (en) Isolated cytokine zalpha11 ligand polypeptide and uses thereof
BG101408A (en) Analogs of keratinocyte growth factor
AU2002307510A1 (en) Cytokine protein family
MY135991A (en) A vaccine-induced hepatits b viral strain and uses thereof
DK0388963T3 (da) Fremgangsmåde til ekspression af et rekombinant gen
AU4765099A (en) Method of genetic modification of a wild type viral sequence
DK0828004T3 (da) Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær
EP1074624A4 (de) Gen 62 des attenuierten windpocken-virusstammes okaund verfahren zur identifikation eines attenuierten, lebenden windpockenvirusstammes unter verwendung dieses genes.
EP0949333A4 (de) Mutierte antigene des masernvirus und die dafür kodierenden gene.
WO2003054010A3 (en) Early stage redox-related apoptosis modulator-2 (esram-2)